Other Articles |

The Methemoglobin Reduction Test for Primaquine-Type Sensitivity of Erythrocytes:  A Simplified Procedure for Detecting a Specific Hypersusceptibility to Drug Hemolysis

George J. Brewer; Alvin R. Tarlov, (M.C.); Alf S. Alving, M.D.
JAMA. 1962;180(5):386-388. doi:10.1001/jama.1962.03050180032008.
Text Size: A A A
Published online

THE INCREASING IMPORTANCE in medicine of the inherited susceptibility to hemolysis, known as primaquine-type sensitivity or erythrocytic glucose-6-phosphate dehydrogenase (G-6-PD) deficiency, has been summarized by Kellermeyer et al., in this issue of THE JOURNAL. Several laboratory methods have been devised for the identification of this primaquine-type sensitivity of red blood cells. The Methemoglobin Reduction Test developed by Brewer et al. has several advantages over previous tests. It is simple and inexpensive to perform; it clearly separates individuals with normal erythrocytes from those with full susceptibility to hemolysis; and it allows semiquantitative evaluation of intermediate susceptibility.

The following simplification of the Methemoglobin Reduction Test increases its value and practicability for use in diagnosis. Certain steps used in the original method have been omitted or modified in order to increase the versatility of the procedure, e.g., the preparation of the incubation tubes in advance. The end-point is determined visually by gross inspection.


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.